Project I- Impact of Hypoxia-Ischemia and/or Inflammation on Microglia in Cerebellum

项目 I- 缺氧缺血和/或炎症对小脑小胶质细胞的影响

基本信息

  • 批准号:
    9979920
  • 负责人:
  • 金额:
    $ 25.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-17 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY: Sensitive periods in neuronal development vary by brain region, sensitivity and vulnerability to disruptive agents. We have discovered that the second postnatal week in the rat is a sensitive period in cerebellar development to dysregulation by inflammation. This sensitive period is characterized by increased production of prostaglandins, in particular PGE2. This sensitive period coincides with a time of increased risk for perinatal H/I (e.g. birth in human infants). The source of the stunting of the Purkinje neuron dendritic tree following inflammation is unknown. Microglia are the brains innate immune cells and serve a variety of functions in both health and disease. We have observed tightly regulated and temporally controlled phagocytic activity of microglia in the developing cerebellum and we hypothesize this plays an important role in normal cerebellar development. We provide evidence that H/I at PN10 increases still further the peak in phagocytosis normally seen at PN17. One of the key signals regulating microglia phagocytic activity is the membrane lipid phosphatidylserine, which is externalized to the outer leaflet and promotes phagocytosis. Hypoxia has been known to stimulate phagocytosis by stressing cells sufficiently to externalize phosphotidylserine. The role of metabolism or lipid rafts in the externalization of this lipid has not been considered, nor have either of these variables been characterized in microglia in a surveying versus activated state. Hypoxic-Ischemic brain injury often occurs following an inflammatory insult, resulting in further injury than would otherwise occur. Whether this is true in the developing cerebellum has not been carefully explored nor have sex differences in hypoxic-ischemic brain or inflammatory injury been considered. We propose three Specific Aims focused on 1) morphometery of Purkinje neurons, granule cells and the deep cerebellar nuclei following H/I with and without inflammation, 2) the role of microglia in neuronal damage induced by H/I with and without inflammation and 3) the impact of tetracycline based antibiotic, Minocycline, as proof of principle and the glutamate transporter modifying antibiotic Ceftriaxone as a potential therapeutic. We will also explore the dietary supplement, choline and conduct behavioral and histological analyses to assess injury and recovery. Data generated by these experiments will provide novel insights into the impact of H/I on the cerebellum and the degree to which it contributes to the impaired cognitive and motor function seen in infants suffering hypoxic-ischemic encephalopathy.
项目概要: 神经元发育的敏感期因大脑区域、对破坏性物质的敏感性和脆弱性而异。我们 发现大鼠出生后第二周是小脑发育的敏感期 炎症引起的失调。这个敏感期的特点是前列腺素的产生增加, 特别是PGE2。这个敏感期恰逢围产期 H/I 风险增加的时期(例如人类出生) 婴儿)。炎症后浦肯野神经元树突树发育迟缓的根源尚不清楚。小胶质细胞 是大脑的先天免疫细胞,在健康和疾病中发挥多种功能。我们严密观察 发育中小脑中小胶质细胞的调节和暂时控制的吞噬活性,我们假设 这在正常小脑发育中起着重要作用。我们提供证据表明 PN10 时的 H/I 仍在增加 此外,吞噬作用的峰值通常出现在 PN17。调节小胶质细胞吞噬活性的关键信号之一是 膜脂磷脂酰丝氨酸,其外化到外叶并促进吞噬作用。缺氧 已知它可以通过对细胞施加足够的压力来刺激吞噬作用,从而使磷脂酰丝氨酸外化。的作用 尚未考虑该脂质外化中的代谢或脂筏,也没有考虑这些变量中的任何一个 已对小胶质细胞处于调查状态与激活状态进行了表征。 缺氧缺血性脑损伤通常发生在炎症损伤后,导致比普通损伤更严重的损伤 否则会发生。这对于正在发育的小脑是否属实还没有被仔细探索过,也没有发生过性行为 考虑了缺氧缺血性脑或炎症损伤的差异。我们提出三个具体目标 1) 浦肯野神经元、颗粒细胞和小脑深部核团在 H/I 有或没有的情况下的形态测量 炎症,2) 小胶质细胞在 H/I 引起的神经元损伤中的作用,有或没有炎症,3) 基于四环素的抗生素米诺环素的影响作为原理证明和谷氨酸转运蛋白修饰 抗生素头孢曲松作为一种潜在的治疗方法。我们还将探讨膳食补充剂、胆碱和行为 行为和组织学分析以评估损伤和恢复。这些实验产生的数据将提供 关于 H/I 对小脑的影响及其对认知受损程度的新见解 患有缺氧缺血性脑病的婴儿中观察到的运动功能和运动功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARGARET M. MCCARTHY其他文献

MARGARET M. MCCARTHY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARGARET M. MCCARTHY', 18)}}的其他基金

Endocannabinoids regulate microglia in developing brain
内源性大麻素调节大脑发育中的小胶质细胞
  • 批准号:
    9028927
  • 财政年份:
    2016
  • 资助金额:
    $ 25.65万
  • 项目类别:
Endocannabinoids regulate microglia in developing brain
内源性大麻素调节大脑发育中的小胶质细胞
  • 批准号:
    10386019
  • 财政年份:
    2016
  • 资助金额:
    $ 25.65万
  • 项目类别:
Endocannabinoids regulate microglia in developing brain
内源性大麻素调节大脑发育中的小胶质细胞
  • 批准号:
    10627742
  • 财政年份:
    2016
  • 资助金额:
    $ 25.65万
  • 项目类别:
Neurogenesis Following Hypoxic Ischemic Neonatal Brain Injury
新生儿缺氧缺血性脑损伤后的神经发生
  • 批准号:
    8067623
  • 财政年份:
    2011
  • 资助金额:
    $ 25.65万
  • 项目类别:
Prostaglandins and Cerebellum Development
前列腺素和小脑发育
  • 批准号:
    9926725
  • 财政年份:
    2010
  • 资助金额:
    $ 25.65万
  • 项目类别:
Prostaglandins and Cerebellum Development
前列腺素和小脑发育
  • 批准号:
    8242868
  • 财政年份:
    2010
  • 资助金额:
    $ 25.65万
  • 项目类别:
Prostaglandins and Cerebellum Development
前列腺素和小脑发育
  • 批准号:
    8608004
  • 财政年份:
    2010
  • 资助金额:
    $ 25.65万
  • 项目类别:
Prostaglandins and Cerebellum Development
前列腺素和小脑发育
  • 批准号:
    8116474
  • 财政年份:
    2010
  • 资助金额:
    $ 25.65万
  • 项目类别:
Prostaglandins and Cerebellum Development
前列腺素和小脑发育
  • 批准号:
    7979917
  • 财政年份:
    2010
  • 资助金额:
    $ 25.65万
  • 项目类别:
Prostaglandins and Cerebellum Development
前列腺素和小脑发育
  • 批准号:
    8534876
  • 财政年份:
    2010
  • 资助金额:
    $ 25.65万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.65万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了